1
|
Recchia M, Ghidini S, Romeo C, Scali F, Maisano AM, Guadagno F, De Luca S, Ianieri A, Alborali GL. An Integrated Analysis of Abattoir Lung Lesion Scores and Antimicrobial Use in Italian Heavy Pig Finishing Farms. Animals (Basel) 2024; 14:1621. [PMID: 38891668 PMCID: PMC11171393 DOI: 10.3390/ani14111621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Revised: 05/28/2024] [Accepted: 05/29/2024] [Indexed: 06/21/2024] Open
Abstract
Respiratory diseases significantly affect intensive pig finishing farms, causing production losses and increased antimicrobial use (AMU). Lesion scoring at slaughter has been recognized as a beneficial practice to evaluate herd management. The integrated analysis of abattoir lesion scores and AMU data could improve decision-making by providing feedback to veterinarians and farmers on the effectiveness of antimicrobial treatments, thus rationalizing their use. This study compared lung and pleural lesion scores collected at Italian pig slaughterhouses with on-farm AMU, estimated through a treatment index per 100 days (TI100). Overall, 24,752 pig carcasses, belonging to 236 batches from 113 finishing farms, were inspected. Bronchopneumonia and chronic pleuritis were detected in 55% and 48% of the examined pigs, respectively. Antimicrobials were administered in 97% of the farms during the six months prior to slaughter (median TI100 = 5.2), notwithstanding compliance with the mandatory withdrawal period. EMA category B (critical) antimicrobials were administered in 15.2% of cases (median TI100 = 0.06). The lung score was not associated with the total AMU, but significant, positive associations were found with the past use of critical antimicrobials (p = 0.041) and macrolides (p = 0.044). This result highlights the potential of abattoir lung lesion monitoring to rationalize antimicrobial stewardship efforts, contributing to AMU reduction.
Collapse
Affiliation(s)
- Matteo Recchia
- Section Diagnostic and Animal Health, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (IZSLER), Via Bianchi 7/9, 25124 Brescia, Italy; (M.R.); (F.S.); (A.M.M.); (F.G.); (G.L.A.)
| | - Sergio Ghidini
- Department of Veterinary Medicine and Animal Sciences, University of Milan, Via dell’Università 6, 26900 Lodi, Italy;
| | - Claudia Romeo
- Section Diagnostic and Animal Health, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (IZSLER), Via Bianchi 7/9, 25124 Brescia, Italy; (M.R.); (F.S.); (A.M.M.); (F.G.); (G.L.A.)
- Center for Evolutionary Hologenomics—Globe Institute, University of Copenhagen, Øster Farimagsgade 5, 1353 Copenhagen, Denmark
| | - Federico Scali
- Section Diagnostic and Animal Health, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (IZSLER), Via Bianchi 7/9, 25124 Brescia, Italy; (M.R.); (F.S.); (A.M.M.); (F.G.); (G.L.A.)
| | - Antonio Marco Maisano
- Section Diagnostic and Animal Health, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (IZSLER), Via Bianchi 7/9, 25124 Brescia, Italy; (M.R.); (F.S.); (A.M.M.); (F.G.); (G.L.A.)
| | - Federica Guadagno
- Section Diagnostic and Animal Health, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (IZSLER), Via Bianchi 7/9, 25124 Brescia, Italy; (M.R.); (F.S.); (A.M.M.); (F.G.); (G.L.A.)
| | | | - Adriana Ianieri
- Department of Food and Drug, Parma University, Via del Taglio 10, 43126 Parma, Italy;
| | - Giovanni Loris Alborali
- Section Diagnostic and Animal Health, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (IZSLER), Via Bianchi 7/9, 25124 Brescia, Italy; (M.R.); (F.S.); (A.M.M.); (F.G.); (G.L.A.)
| |
Collapse
|
2
|
Scali F, Ganio S, Roullet C, Ruffier M, Bergagna S, Pagliasso G, Romeo C, Formenti N, Maisano AM, Santucci G, Tonni M, Guadagno F, Mazza F, Guarneri F, Bontempi G, Candela L, Alborali GL. Regional-Scale Analysis of Antimicrobial Usage in Smallholder Cattle Herds (Aosta Valley, Italy): Why Surveillance Matters. Antibiotics (Basel) 2024; 13:204. [PMID: 38534639 DOI: 10.3390/antibiotics13030204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2024] [Revised: 02/16/2024] [Accepted: 02/20/2024] [Indexed: 03/28/2024] Open
Abstract
Optimising antimicrobial usage (AMU) in livestock is pivotal to counteract the emergence of antimicrobial resistance. We analysed AMU in more than 1000 cattle herds over 11 years (2008-2018) in the Aosta Valley (Italy), a region where 80% of farms house less than 50 cattle. Dairy cows accounted for over 95% of AMU. AMU was estimated using the defined daily dose animal for Italy (DDDAit) per biomass for the whole herd and a treatment incidence 100 (TI100) for cows. Average annual herd-level AMU was low, with 3.6 DDDAit/biomass (range: 3.2-4.0) and 1.2 TI100 in cows (range: 1.1-1.3). Third and fourth generation cephalosporins, which are critical for human medicine, represented almost 10% of usage, and intramammary antimicrobials accounted for over 60%. We detected significant downward temporal trends in total AMU, as well as a positive relationship with herd size. The magnitude of such effects was small, leaving scant room for further reduction. However, the frequent use of critical antimicrobials and intramammary products should be addressed, following the principles of prudent AMU. Our findings highlight the importance of monitoring AMU even in low-production, smallholding contexts where a low usage is expected, to identify any deficiencies and implement interventions for further AMU optimisation.
Collapse
Affiliation(s)
- Federico Scali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Sandra Ganio
- Azienda USL della Valle d'Aosta, SC Igiene Allevamenti, 11100 Aosta, Italy
| | - Claudio Roullet
- Azienda USL della Valle d'Aosta, SC Igiene Allevamenti, 11100 Aosta, Italy
| | - Mauro Ruffier
- Assessorato Sanità, Salute e Politiche Sociali della Valle d'Aosta, Igiene e Sanità Pubblica Veterinaria, 11100 Aosta, Italy
| | - Stefania Bergagna
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 25124 Turin, Italy
| | - Giulia Pagliasso
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 25124 Turin, Italy
- Azienda Sanitaria Locale di Ciriè, Chivasso e Ivrea, 10073 Ciriè, Italy
| | - Claudia Romeo
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
- Globe Institute, University of Copenhagen, 1350 København, Denmark
| | - Nicoletta Formenti
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Antonio Marco Maisano
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Giovanni Santucci
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Matteo Tonni
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Federica Guadagno
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Francesca Mazza
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Flavia Guarneri
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Giorgio Bontempi
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| | - Loredana Candela
- Ministero della Salute della Repubblica Italiana, 00144 Rome, Italy
| | - Giovanni Loris Alborali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, 25124 Brescia, Italy
| |
Collapse
|
3
|
Fabrile MP, Ghidini S, Caligiani A, Scali F, Varrà MO, Lolli V, Alborali GL, Ianieri A, Zanardi E. 1H NMR Metabolomics on Pigs' Liver Exposed to Antibiotics Administration: An Explorative Study. Foods 2023; 12:4259. [PMID: 38231703 DOI: 10.3390/foods12234259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2023] [Revised: 11/18/2023] [Accepted: 11/22/2023] [Indexed: 01/19/2024] Open
Abstract
An untargeted Nuclear Magnetic Resonance (NMR) spectroscopy-based metabolomics approach was applied as a first attempt to explore the metabolome of pigs treated with antibiotics. The final goal was to investigate the possibility of discriminating between antibiotic-treated (TX group) and untreated pigs (CTRL group), with the further perspective of identifying the authentication tools for antibiotic-free pork supply chains. In particular, 41 samples of pig liver were subjected to a biphasic extraction to recover both the polar and the non-polar metabolites, and the 1H NMR spectroscopy analysis was performed on the two separate extracts. Unsupervised (principal component analysis) and supervised (orthogonal partial least squares discriminant analysis) multivariate statistical analysis of 1H NMR spectra data in the range 0-9 ppm provided metabolomic fingerprinting useful for the discrimination of pig livers based on the antibiotic treatment to which they were exposed. Moreover, within the signature patterns, significant discriminating metabolites were identified among carbohydrates, choline and derivatives, amino acids and some lipid-class molecules. The encouraging findings of this exploratory study showed the feasibility of the untargeted metabolomic approach as a novel strategy in the authentication framework of pork supply chains and open a new horizon for a more in-depth investigation.
Collapse
Affiliation(s)
- Maria Pia Fabrile
- Department of Food and Drug, University of Parma, Strada del Taglio, 10, 43126 Parma, Italy
| | - Sergio Ghidini
- Department of Food and Drug, University of Parma, Strada del Taglio, 10, 43126 Parma, Italy
| | - Augusta Caligiani
- Department of Food and Drug, University of Parma, Strada del Taglio, 10, 43126 Parma, Italy
| | - Federico Scali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Via A. Bianchi 9, 25124 Brescia, Italy
| | - Maria Olga Varrà
- Department of Food and Drug, University of Parma, Strada del Taglio, 10, 43126 Parma, Italy
| | - Veronica Lolli
- Department of Food and Drug, University of Parma, Strada del Taglio, 10, 43126 Parma, Italy
| | - Giovanni Loris Alborali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Via A. Bianchi 9, 25124 Brescia, Italy
| | - Adriana Ianieri
- Department of Food and Drug, University of Parma, Strada del Taglio, 10, 43126 Parma, Italy
| | - Emanuela Zanardi
- Department of Food and Drug, University of Parma, Strada del Taglio, 10, 43126 Parma, Italy
| |
Collapse
|
4
|
Lungu BC, Hutu I, Barrow PA. Molecular Characterisation of Antimicrobial Resistance in E. coli Isolates from Piglets in the West Region of Romania. Antibiotics (Basel) 2023; 12:1544. [PMID: 37887245 PMCID: PMC10604006 DOI: 10.3390/antibiotics12101544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2023] [Revised: 10/10/2023] [Accepted: 10/12/2023] [Indexed: 10/28/2023] Open
Abstract
Antibiotics are widely used for prophylaxis and therapy, reducing morbidity and mortality produced by bacterial pathogensin pigs, including infections caused by Escherichia coli. The aim of this study was to characterise antibiotic resistance phenotypes and genotypes in E. coli isolates in pigs in West Romanian grower farms. Differential phenotypic susceptibility profiles and the contribution of resistance genes to phenotypic expression of susceptibility or resistance were evaluated. A total of 76 E. coli isolates were identified and confirmed by the MicroScan Walk Away System. The occurrence of four resistance genes, ampC, blaZ, blaTEM and tetK in strains resistant to 13 antibiotics was assessed. Of the E. coli isolates, 0% showed resistance to meropenem, 3.9% to tigecycline and 10.5% to piperacillin/tazobactam, whereas, in contrast, 100% were resistant to ampicillin and mezlocillin, 76.31% to piperacillin and 59.3% to tetracycline. The prevalence of resistance genes in resistant isolates detected by q-PCR analysis was 97.0% for ampC, 96% for blaZ, 32.9% for blaTEM and 58.8% for tetK. Penetrance (the proportion of individuals carrying a particular variant of a gene that also expresses an associated trait) was 50% for ampC (32% for amoxicillin/clavulanate, 62% for cefazolin, 32% for cefepime, 100% for cefotaxime, 56% for cefuroxime and 99% for ampicillin), 65% for blaZ (32% for amoxicillin/clavulanate and 99% for ampicillin), 51% for blaTEM (81% for piperacillin) and 44% for the tetK gene (83% for tetracycline). The result of phenotypic antibiotic resistance testing may indicate the presence of plasmid-borne resistance, with a diagnostic odds ratio of a positive phenotypic resistance for tetK being 4.52. As a management decision, the maximum penetrance admitted for using a specific antibiotic for E. coli infections in pigs is recommended to be less than 20%.
Collapse
Affiliation(s)
- Bianca Cornelia Lungu
- Horia Cernescu Research Unit, Faculty of Veterinary Medicine, University of Life Sciences King Michael I, Calea Aradului 119, 300645 Timisoara, Romania;
| | - Ioan Hutu
- Horia Cernescu Research Unit, Faculty of Veterinary Medicine, University of Life Sciences King Michael I, Calea Aradului 119, 300645 Timisoara, Romania;
| | - Paul Andrew Barrow
- Horia Cernescu Research Unit, Faculty of Veterinary Medicine, University of Life Sciences King Michael I, Calea Aradului 119, 300645 Timisoara, Romania;
- School of Veterinary Medicine, University of Surrey, Daphne Jackson Rd., Guildford, Surrey GU2 7AL, UK
| |
Collapse
|
5
|
Ghidini S, Scali F, Romeo C, Guadagno F, Maisano AM, De Luca S, Varrà MO, Conter M, Ianieri A, Zanardi E, Alborali GL. A Preliminary Study on the Relationship between Gastric Lesions and Anti-Inflammatory Drug Usage in Heavy Pigs. Vet Sci 2023; 10:551. [PMID: 37756075 PMCID: PMC10535441 DOI: 10.3390/vetsci10090551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 08/29/2023] [Accepted: 08/31/2023] [Indexed: 09/28/2023] Open
Abstract
Gastric lesions in pigs cause welfare and economic losses. Their prevalence in heavy pigs reared for premium products (e.g., Parma ham) requires further investigation. Stress, nutrition, and farm management are known risk factors, but the effects of steroidal and non-steroidal anti-inflammatory drugs (NSAIDs) are largely unknown. The aim of this study was to evaluate the prevalence of gastric lesions in Italian heavy pigs and their possible association with the use of anti-inflammatory drugs. A total of 9371 pig stomachs from 76 farms were evaluated. Among these, 20.3% showed no lesions, while 30.7%, 42.1%, and 6.8% were scored 1, 2 and 3, respectively. A tendency for an inverse relationship with farm size emerged. The use of steroids and NSAIDs was estimated by calculating a treatment incidence per 1000 (TI1000) in a subset of 36 farms. At least one prescription for NSAIDs and/or steroids was found in 80.6% of the farms (55.6% used NSAIDs and 63.9% used steroids). Median TI1000 was 0.07 (range: 0-30.1) and 0.18 (range: 0-6.2) for NSAIDs and steroids, respectively. Gastric scores were positively associated with NSAID use, but not with steroid use. Although the role of these drugs in gastric lesions needs to be further clarified, these findings suggest a cautious use of non-selective NSAIDs.
Collapse
Affiliation(s)
- Sergio Ghidini
- Department of Food and Drug, University of Parma, Strada del Taglio 10, 43126 Parma, Italy; (S.G.); (S.D.L.); (M.O.V.); (A.I.); (E.Z.)
| | - Federico Scali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, 25124 Brescia, Italy; (F.S.); (C.R.); (F.G.); (A.M.M.); (G.L.A.)
| | - Claudia Romeo
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, 25124 Brescia, Italy; (F.S.); (C.R.); (F.G.); (A.M.M.); (G.L.A.)
| | - Federica Guadagno
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, 25124 Brescia, Italy; (F.S.); (C.R.); (F.G.); (A.M.M.); (G.L.A.)
| | - Antonio Marco Maisano
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, 25124 Brescia, Italy; (F.S.); (C.R.); (F.G.); (A.M.M.); (G.L.A.)
| | - Silvio De Luca
- Department of Food and Drug, University of Parma, Strada del Taglio 10, 43126 Parma, Italy; (S.G.); (S.D.L.); (M.O.V.); (A.I.); (E.Z.)
| | - Maria Olga Varrà
- Department of Food and Drug, University of Parma, Strada del Taglio 10, 43126 Parma, Italy; (S.G.); (S.D.L.); (M.O.V.); (A.I.); (E.Z.)
| | - Mauro Conter
- Department of Veterinary Medicine Sciences, University of Parma, Strada del Taglio 10, 43126 Parma, Italy
| | - Adriana Ianieri
- Department of Food and Drug, University of Parma, Strada del Taglio 10, 43126 Parma, Italy; (S.G.); (S.D.L.); (M.O.V.); (A.I.); (E.Z.)
| | - Emanuela Zanardi
- Department of Food and Drug, University of Parma, Strada del Taglio 10, 43126 Parma, Italy; (S.G.); (S.D.L.); (M.O.V.); (A.I.); (E.Z.)
| | - Giovanni Loris Alborali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, 25124 Brescia, Italy; (F.S.); (C.R.); (F.G.); (A.M.M.); (G.L.A.)
| |
Collapse
|
6
|
Moura P, Sandberg M, Høg BB, Niza-Ribeiro J, Nielsen EO, Alban L. Characterisation of antimicrobial usage in Danish pigs in 2020. Front Vet Sci 2023; 10:1155811. [PMID: 37180070 PMCID: PMC10167271 DOI: 10.3389/fvets.2023.1155811] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 04/05/2023] [Indexed: 05/15/2023] Open
Abstract
Introduction Denmark is one of the world's largest exporters of pigs and pig meat, so the sector plays an important role in the national antimicrobial use (AMU). The Danish government has run antimicrobial stewardship programs in collaboration with the pig industry for more than 25 years. These have resulted in substantial overall reductions in total AMU and limiting the use of fluoroquinolones, the 3rd and 4th generation cephalosporines and the polymyxin colistin. To understand where further reductions in AMU could take place, it is necessary to investigate which antimicrobials are being used, how, and for which reasons. Materials and methods We characterized the AMU in the Danish pig sector in 2020, providing new analytical insights based on data retrieved from the VetStat database. The AMU data were segmented into classes, routes of administration, treatment indications and age groups, and interpreted as an outcome of the interventions taken. We evaluated the current AMU regarding choice of antimicrobial class. Moreover, we discussed how to further improve the antimicrobial stewardship in Danish pig production to achieve additional reductions without jeopardizing animal welfare. Where relevant, two pig veterinary specialists were consulted. Results In 2020, 43.3 mg antimicrobials per population correction unit (PCU) were ascribed to the Danish pig sector. There was practically no use of fluoroquinolones, 3rd and 4th generation cephalosporins and polymyxins. Weaners related to 45% of the total AMU in pigs when measured in tonnes and 81% when measured in defined animal daily doses, of these 76% were ascribed to gastrointestinal indications and overall, 83% were administered perorally. Conclusion To enable further reductions in AMU, it should be investigated how and when to replace group treatments (e.g., all animals in section or a pen) with individual treatments. Moreover, prevention of disease and promotion of animal health should be prioritized, e.g., through focus on feed, vaccination, biosecurity, and disease eradication.
Collapse
Affiliation(s)
- Pedro Moura
- National Food Institute, Technical University of Denmark, Lyngby, Denmark
| | - Marianne Sandberg
- National Food Institute, Technical University of Denmark, Lyngby, Denmark
| | - Birgitte Borck Høg
- National Food Institute, Technical University of Denmark, Lyngby, Denmark
| | - João Niza-Ribeiro
- Departamento de Estudo de Populações, ICBAS, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
- Epidemiology Research Unit (EPIUnit), Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal
| | | | - Lis Alban
- Department for Food Safety, Veterinary Issues and Risk Analysis, Danish Agriculture and Food Council, Copenhagen, Denmark
- Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark
| |
Collapse
|
7
|
Jansen W, van Hout J, Wiegel J, Iatridou D, Chantziaras I, De Briyne N. Colistin Use in European Livestock: Veterinary Field Data on Trends and Perspectives for Further Reduction. Vet Sci 2022; 9:650. [PMID: 36423099 PMCID: PMC9697203 DOI: 10.3390/vetsci9110650] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Revised: 11/17/2022] [Accepted: 11/19/2022] [Indexed: 09/29/2023] Open
Abstract
Polymyxin E (colistin) is a medically important active substance both in human and veterinary medicine. Colistin has been used in veterinary medicine since the 1950s. Due to the discovery of the plasmid-borne mcr gene in 2015 and the simultaneously increased importance in human medicine as a last-resort antibiotic, the use of colistin for animals was scrutinised. Though veterinary colistin sales dropped by 76.5% between 2011 to 2020, few studies evaluated real-world data on the use patterns of colistin in different European countries and sectors. A survey among veterinarians revealed that 51.9% did not use or ceased colistin, 33.4% decreased their use, 10.4% stabilised their use, and 2.7% increased use. The most important indications for colistin use were gastrointestinal diseases in pigs followed by septicaemia in poultry. A total of 106 (16.0%) responding veterinarians reported governmental/industry restrictions regarding colistin use, most commonly mentioning "use only after susceptibility testing" (57%). In brief, colistin was perceived as an essential last-resort antibiotic in veterinary medicine for E. coli infections in pigs and poultry, where there is no alternative legal, safe, and efficacious antimicrobial available. To further reduce the need for colistin, synergistic preventive measures, including improved biosecurity, husbandry, and vaccinations, must be employed.
Collapse
Affiliation(s)
- Wiebke Jansen
- Federation of Veterinarians of Europe (FVE), Rue Victor Oudart 7, 1030 Brussels, Belgium
| | - Jobke van Hout
- Royal GD, Arnsbergstraat 7, 7418 EZ Deventer, The Netherlands
| | - Jeanine Wiegel
- Royal GD, Arnsbergstraat 7, 7418 EZ Deventer, The Netherlands
| | - Despoina Iatridou
- Federation of Veterinarians of Europe (FVE), Rue Victor Oudart 7, 1030 Brussels, Belgium
| | - Ilias Chantziaras
- Veterinary Epidemiology Unit, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| | - Nancy De Briyne
- Federation of Veterinarians of Europe (FVE), Rue Victor Oudart 7, 1030 Brussels, Belgium
| |
Collapse
|
8
|
Dewulf J, Joosten P, Chantziaras I, Bernaerdt E, Vanderhaeghen W, Postma M, Maes D. Antibiotic Use in European Pig Production: Less Is More. Antibiotics (Basel) 2022; 11:1493. [PMID: 36358148 PMCID: PMC9686698 DOI: 10.3390/antibiotics11111493] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 10/24/2022] [Accepted: 10/25/2022] [Indexed: 07/25/2023] Open
Abstract
The goal of this study is to describe the current use of antibiotics in the European pig industry based on an extensive literature review. To achieve this, an overview of results from national (n = 15) and multi-country (n = 2) cross-sectional and longitudinal (n = 2) surveys, which describe antimicrobial use in pigs, is presented. Results are further linked to the outcome of the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project. Overall, it was found that weaned piglets received the most antibiotics, followed by suckling piglets resulting in over 80% of the treatments being administered to animals before 10 weeks of age. Furthermore, it was observed that antibiotic use (ABU) was significantly associated across age categories, indicating that farms with a high use in piglets also used more antibiotics in their finishers. This may, among other things, be explained by farmers' habits and behavior. However, above all, the studies showed surprisingly large differences in ABU between the countries. These differences may be related to the differences in disease prevalence and/or differences in the level of biosecurity. However, they may also reflect variations in rules and regulations between countries and/or a difference in attitude towards ABU of farmers and veterinarians that are not necessarily linked to the true animal health situation. Furthermore, it was observed that already a substantial proportion of the European pig production is able to successfully raise pigs without any group treatments, indicating that it is possible to rear pigs without systematic use of antibiotics. Based on the ESVAC data, a decline of 43.2% was observed in sales of antibiotics for animals in Europe between 2011 and 2020. To enable efficient antimicrobial quantification and stewardship, 15 European countries have already established systems for herd level monitoring ABU in pigs.
Collapse
Affiliation(s)
- Jeroen Dewulf
- Veterinary Epidemiology Unit, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| | - Philip Joosten
- Veterinary Epidemiology Unit, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| | - Ilias Chantziaras
- Veterinary Epidemiology Unit, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| | - Elise Bernaerdt
- Unit of Porcine Health Management, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| | - Wannes Vanderhaeghen
- Centre of Expertise on Antimicrobial Consumption and Resistance in Animals (AMCRA), Galileolaan 5/02, 1210 Brussels, Belgium
| | - Merel Postma
- Veterinary Epidemiology Unit, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| | - Dominiek Maes
- Unit of Porcine Health Management, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium
| |
Collapse
|
9
|
Jerab J, Jansen W, Blackwell J, van Hout J, Palzer A, Lister S, Chantziaras I, Dewulf J, De Briyne N. Real-World Data on Antibiotic Group Treatment in European Livestock: Drivers, Conditions, and Alternatives. Antibiotics (Basel) 2022; 11:1046. [PMID: 36009915 PMCID: PMC9404736 DOI: 10.3390/antibiotics11081046] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 07/29/2022] [Accepted: 08/01/2022] [Indexed: 02/05/2023] Open
Abstract
Major efforts have been made by veterinary professionals to reduce the need for antibiotic use in animals. An online survey launched by the Federation of Veterinarians of Europe (FVE) aimed to gather responses from practicing veterinarians with field experience in metaphylactic livestock group treatment. Only 17% of all veterinarians (n = 183/1087, all species-specific responses merged) applied metaphylactic group treatments to 75% or more of all their treatments. Significantly less metaphylactic group treatments were reported in mixed practices (p = 0.002) and practices specialized in cattle (p < 0.001) as well as small (p = 0.007) and very small practices (p = 0.009). Gram-negative bacteria, mostly composed of Enterobacteriaceae and Pasteurellaceae, were considered by 75.3% (n = 967/1385) as the most devastating bacterial pathogens. Respondents alleged morbidity (20.1%, n = 201/998) and mortality (42.2%, n = 421/998) as major consequences for animal health and welfare if metaphylaxis would be banned. Responding veterinarians pointed towards vaccinations; improved biosecurity, including hygiene measures; and improved herd health management as the three most effective alternative measures to prevent metaphylactic treatment. However, more research is needed on how to implement appropriate alternatives in a holistic hurdle approach. Active support on a national level will be necessary for the development and application of targeted veterinary treatment guidelines for practitioners, which promote the understanding of drivers and include initiation criteria for metaphylactic group treatments in livestock.
Collapse
Affiliation(s)
- Julia Jerab
- Federation of Veterinarians of Europe (FVE), Rue Victor Oudart 7, 1030 Brussels, Belgium; (J.J.); (W.J.)
| | - Wiebke Jansen
- Federation of Veterinarians of Europe (FVE), Rue Victor Oudart 7, 1030 Brussels, Belgium; (J.J.); (W.J.)
| | - John Blackwell
- Brownlow Veterinary Group Ltd., Ellesmere Business Park, Oswestry Rd., Ellesmere SY12 0EW, UK;
| | - Jobke van Hout
- Royal GD, Arnsbergstraat 7, 7418 EZ Deventer, The Netherlands;
| | - Andreas Palzer
- Veterinary Pig Practice Scheidegg, Bahnhofstrasse 30, D-88175 Scheidegg, Germany;
| | - Stephen Lister
- Lister Veterinary Consultancy, 125 The Street, Norwich NR8 5DF, UK;
| | - Ilias Chantziaras
- Veterinary Epidemiology Unit, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium; (I.C.); (J.D.)
| | - Jeroen Dewulf
- Veterinary Epidemiology Unit, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium; (I.C.); (J.D.)
| | - Nancy De Briyne
- Federation of Veterinarians of Europe (FVE), Rue Victor Oudart 7, 1030 Brussels, Belgium; (J.J.); (W.J.)
| |
Collapse
|
10
|
Trevisi P, Amatucci L, Ruggeri R, Romanelli C, Sandri G, Luise D, Canali M, Bosi P. Pattern of Antibiotic Consumption in Two Italian Production Chains Differing by the Endemic Status for Porcine Reproductive and Respiratory Syndrome. Front Vet Sci 2022; 9:840716. [PMID: 35419448 PMCID: PMC8996257 DOI: 10.3389/fvets.2022.840716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Accepted: 02/17/2022] [Indexed: 11/13/2022] Open
Abstract
The aim of this case study was to quantify antibiotic (AB) use in Italian weaning (W) and fattening (F) units differentiated for porcine reproductive and respiratory syndrome (PRRS) occurrence. Farms were classified as either PRRS negative (–) or PRRS positive (+) based on the circulation of the virus among the animals. In all the farms, the modified live PRRS virus (PRRSV) vaccine was provided to all the animals. In the PRRS– farms, the level of circulating antibodies was low, and the disease, in its clinical form, did not occur. In the PRRS+ farms, the level of circulating antibodies against the virus was high, and the disease was recurrent. Data regarding AB consumption were collected from 2017 to 2020, and the active compounds (ACs) were expressed as milligrams of AC/total kilogram of body weight (BW) produced. Each AC was classified into one of four categories according to the European Medicines Agency classification of ABs for prudent and responsible use in animals: Avoid, Restrict, Caution, and Prudence. Data regarding the ACs in each category were analyzed using a linear model that included production phase, PRRS status, and their interaction as factors. Performance parameters, average age of the pigs at the end of each phase, daily live weight gain, feed-to-gain ratio, total losses, cost index, and medication costs were significantly influenced by the PRRS chain. The use of class B ABs was not affected by production phase or PRRS status. Conversely, for class C ABs, interaction between the two factors (p = 0.02) was observed; W/PRRS+ and F/PRRS+ showed the greatest AB use for this class (p = 0.003). For class D ABs, the interaction was significant (p = 0.01); class C and D ABs were used more in the weaning (p = 0.07) than in the fattening phase (p = 0.003). For the weaning phase, the use of class C and D ABs was greater in the PRRS+ than in the PRRS– chain (p < 0.01). In conclusion, PRRS status affected the growth of pigs and economic performance. Moreover, PRRS status significantly influenced the use of ABs during all the growing periods with the greatest impact being on the weaning phase.
Collapse
Affiliation(s)
- Paolo Trevisi
- Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy
| | - Laura Amatucci
- Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy
| | - Roberta Ruggeri
- Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy
| | - Costanza Romanelli
- Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy
| | | | - Diana Luise
- Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy
| | - Massimo Canali
- Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy
| | - Paolo Bosi
- Department of Agricultural and Food Sciences, University of Bologna, Bologna, Italy
| |
Collapse
|
11
|
Albernaz-Gonçalves R, Olmos Antillón G, Hötzel MJ. Linking Animal Welfare and Antibiotic Use in Pig Farming-A Review. Animals (Basel) 2022; 12:216. [PMID: 35049838 PMCID: PMC8773261 DOI: 10.3390/ani12020216] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Revised: 01/09/2022] [Accepted: 01/12/2022] [Indexed: 12/16/2022] Open
Abstract
Preventative measures, such as biosecurity and vaccinations, are essential but not sufficient to ensure high standards of health in pig production systems. Restrictive, barren housing and many widely used management practices that cause pain and stress predispose high-performance pigs reared in intensive systems to disease. In this context, antibiotics are used as part of the infrastructure that sustains health and high levels of production in pig farms. Antimicrobial resistance (AMR) is a global emergency affecting human and animal health, and the use of antibiotics (AMU) in intensive livestock farming is considered an important risk factor for the emergence and spread of resistant bacteria from animals to humans. Tackling the issue of AMR demands profound changes in AMU, e.g., reducing their use for prophylaxis and ending it for growth promotion. In support of such recommendations, we revise the link between animal welfare and AMU and argue that it is crucial to sustainably reduce AMU while ensuring that pigs can live happy lives. In support of such recommendations, we aimed to revise the link between animal welfare and AMU in pigs by analysing stress factors related to housing and management and their impact on pig welfare. In particular, we reviewed critical management practices that increase stress and, therefore, pigs' susceptibility to disease and reduce the quality of life of pigs. We also reviewed some alternatives that can be adopted in pig farms to improve animal welfare and that go beyond the reduction in stress. By minimising environmental and management stressors, pigs can become more immunocompetent and prepared to overcome pathogenic challenges. This outcome can contribute to reducing AMU and the risk of AMR while simultaneously improving the quality of life of pigs and, ultimately, maintaining the pig industry's social license.
Collapse
Affiliation(s)
- Rita Albernaz-Gonçalves
- Campus Santa Rosa do Sul, Instituto Federal Catarinense, Santa Rosa do Sul 88965-000, SC, Brazil;
- Laboratório de Etologia Aplicada e Bem-Estar Animal, Universidade Federal de Santa Catarina, Rod. Admar Gonzaga 1346, Itacorubi, Florianópolis 88034-001, SC, Brazil
| | - Gabriela Olmos Antillón
- Department of Clinical Sciences, Swedish University of Agricultural Sciences, 75007 Uppsala, Sweden;
| | - Maria José Hötzel
- Laboratório de Etologia Aplicada e Bem-Estar Animal, Universidade Federal de Santa Catarina, Rod. Admar Gonzaga 1346, Itacorubi, Florianópolis 88034-001, SC, Brazil
| |
Collapse
|
12
|
Risk Factors for Antimicrobial Use on Irish Pig Farms. Animals (Basel) 2021; 11:ani11102828. [PMID: 34679849 PMCID: PMC8532697 DOI: 10.3390/ani11102828] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Revised: 09/22/2021] [Accepted: 09/25/2021] [Indexed: 11/17/2022] Open
Abstract
Simple Summary Antimicrobial resistance (AMR) is a major threat to public health. There are concerns that antimicrobial use (AMU) in agriculture has a role in the development of AMR. Pigs are one of the main consumers of veterinary antimicrobials and a better understanding of the drivers for AMU in this sector will help in efforts to reduce use. The aim of this study was to investigate the associations between antimicrobial use, farm characteristics, biosecurity, the presence of respiratory disease on the farm and health management practices on Irish pig farms. Farms that manufactured their feed on-site had lower total AMU than farms that purchased their feed from a feed mill. Higher levels of lung abscesses and pericarditis (inflammation of the lining around the heart), both indicators of respiratory disease, were associated with increased AMU. Higher levels of pericarditis were also associated with increased use of critically important antimicrobials. Farms vaccinating against swine influenza also had higher AMU. Farms that administered prophylactic antimicrobial treatments to piglets had higher use of individual treatments and critically important antimicrobials. The results from this study show that prophylaxis and respiratory disease are the main drivers of AMU on Irish pig farms. These findings highlight areas of farm management where interventions may aid in reducing AMU on Irish pig farms. Abstract The threat to public health posed by antimicrobial resistance in livestock production means that the pig sector is a particular focus for efforts to reduce antimicrobial use (AMU). This study sought to investigate the risk factors for AMU in Irish pig production. Antimicrobial use data were collected from 52 farrow-to-finish farms. The risk factors investigated were farm characteristics and performance, biosecurity practices, prevalence of pluck lesions at slaughter and serological status for four common respiratory pathogens and vaccination and prophylactic AMU practices. Linear regression models were used for quantitative AMU analysis and risk factors for specific AMU practices were investigated using logistic regression. Farms that milled their own feed had lower total AMU (p < 0.001), whereas higher finisher mortality (p = 0.043) and vaccinating for swine influenza (p < 0.001) increased AMU. Farms with higher prevalence of pericarditis (p = 0.037) and lung abscesses (p = 0.046) used more group treatments. Farms with higher prevalence of liver milk spot lesions (p = 0.018) and farms practising prophylactic AMU in piglets (p = 0.03) had higher numbers of individual treatments. Farms practising prophylactic AMU in piglets (p = 0.002) or sows (p = 0.062) had higher use of cephalosporins and fluoroquinolones. This study identified prophylactic use and respiratory disease as the main drivers for AMU in Irish pig production. These findings highlight areas of farm management where interventions may aid in reducing AMU on Irish pig farms.
Collapse
|
13
|
Mazza F, Scali F, Formenti N, Romeo C, Tonni M, Ventura G, Bertocchi L, Lorenzi V, Fusi F, Tolini C, Clemente GF, Guadagno F, Maisano AM, Santucci G, Candela L, Romeo GA, Alborali GL. The Relationship between Animal Welfare and Antimicrobial Use in Italian Dairy Farms. Animals (Basel) 2021; 11:ani11092575. [PMID: 34573541 PMCID: PMC8471712 DOI: 10.3390/ani11092575] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2021] [Revised: 08/28/2021] [Accepted: 08/31/2021] [Indexed: 12/22/2022] Open
Abstract
Information regarding the relationship between animal welfare (AW) and antimicrobial use (AMU) in dairy cows is limited. The current study aimed to investigate this relationship on Italian farms and to identify potential targets of AMU reduction. The study was performed at 79 Italian dairy farms housing over 15,000 cows during 2019. AW was scored with an on-farm protocol assessing farm management and staff training, housing systems, and animal-based measures. AMU was estimated using a defined daily dose per kg of animal biomass (DDDAit/biomass) for Italy. The median AW score was 73% (range: 56.6-86.8%). The median AMU was 4.8 DDDAit/biomass (range: 0-11.8). No relationship between the total AMU and AW was found. Management and staff training were positively associated with the use of the European Medicines Agency's category B antimicrobials, which are critical for human medicine, and with intramammary products for dry cow therapy. In those farms, antimicrobial stewardship should aim to reduce the category B antimicrobials and selective dry cow therapy. Our results underline the importance of implementing both an integrated monitoring system (AW, AMU, etc.) and antimicrobial stewardship tailored to the specific needs of each dairy farm.
Collapse
Affiliation(s)
- Francesca Mazza
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
- Centro di Referenza Nazionale per il Benessere Animale (CReNBA), Via Bianchi 7/9, 25124 Brescia, Italy
| | - Federico Scali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
- Correspondence:
| | - Nicoletta Formenti
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
| | - Claudia Romeo
- Department of Food and Drug, Parma University, Via del Taglio 10, 43126 Parma, Italy;
| | - Matteo Tonni
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
| | - Giordano Ventura
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
| | - Luigi Bertocchi
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
- Centro di Referenza Nazionale per il Benessere Animale (CReNBA), Via Bianchi 7/9, 25124 Brescia, Italy
| | - Valentina Lorenzi
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
- Centro di Referenza Nazionale per il Benessere Animale (CReNBA), Via Bianchi 7/9, 25124 Brescia, Italy
| | - Francesca Fusi
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
- Centro di Referenza Nazionale per il Benessere Animale (CReNBA), Via Bianchi 7/9, 25124 Brescia, Italy
| | - Clara Tolini
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
- Centro di Referenza Nazionale per il Benessere Animale (CReNBA), Via Bianchi 7/9, 25124 Brescia, Italy
| | - Gian Filippo Clemente
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
- Centro di Referenza Nazionale per il Benessere Animale (CReNBA), Via Bianchi 7/9, 25124 Brescia, Italy
| | - Federica Guadagno
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
| | - Antonio Marco Maisano
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
| | - Giovanni Santucci
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
| | - Loredana Candela
- Italian Ministry of Health, Viale Giorgio Ribotta 5, 00144 Rome, Italy; (L.C.); (G.A.R.)
| | - Gianluca Antonio Romeo
- Italian Ministry of Health, Viale Giorgio Ribotta 5, 00144 Rome, Italy; (L.C.); (G.A.R.)
| | - Giovanni Loris Alborali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’ (I.Z.S.L.E.R.), Via Bianchi 7/9, 25124 Brescia, Italy; (F.M.); (N.F.); (M.T.); (G.V.); (L.B.); (V.L.); (F.F.); (C.T.); (G.F.C.); (F.G.); (A.M.M.); (G.S.); (G.L.A.)
| |
Collapse
|
14
|
Formenti N, Calò S, Parisio G, Guarneri F, Birbes L, Pitozzi A, Scali F, Tonni M, Guadagno F, Giovannini S, Salogni C, Ianieri A, Bellini S, Pasquali P, Alborali GL. ESBL/AmpC-Producing Escherichia coli in Wild Boar: Epidemiology and Risk Factors. Animals (Basel) 2021; 11:ani11071855. [PMID: 34206498 PMCID: PMC8300396 DOI: 10.3390/ani11071855] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Revised: 06/10/2021] [Accepted: 06/20/2021] [Indexed: 11/16/2022] Open
Abstract
The complex health problem of antimicrobial resistance (AMR) involves many host species, numerous bacteria and several routes of transmission. Extended-spectrum β-lactamase and AmpC (ESBL/AmpC)-producing Escherichia coli are among the most important strains. Moreover, wildlife hosts are of interest as they are likely antibiotics free and are assumed as environmental indicators of AMR contamination. Particularly, wild boar (Sus scrofa) deserves attention because of its increased population densities, with consequent health risks at the wildlife-domestic-human interface, and the limited data available on AMR. Here, 1504 wild boar fecal samples were microbiologically and molecularly analyzed to investigate ESBL/AmpC-producing E. coli and, through generalized linear models, the effects of host-related factors and of human population density on their spread. A prevalence of 15.96% of ESBL/AmpC-producing E. coli, supported by blaCTX-M (12.3%), blaTEM (6.98%), blaCMY (0.86%) and blaSHV (0.47%) gene detection, emerged. Young animals were more colonized by ESBL/AmpC strains than older subjects, as observed in domestic animals. Increased human population density leads to increased blaTEM prevalence in wild boar, suggesting that spatial overlap may favor this transmission. Our results show a high level of AMR contamination in the study area that should be further investigated. However, a role of wild boar as a maintenance host of AMR strains emerged.
Collapse
Affiliation(s)
- Nicoletta Formenti
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
- Correspondence:
| | - Stefania Calò
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Giovanni Parisio
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Flavia Guarneri
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Laura Birbes
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Alessandra Pitozzi
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Federico Scali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Matteo Tonni
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Federica Guadagno
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Stefano Giovannini
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Cristian Salogni
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Adriana Ianieri
- Dipartimento di Scienze degli Alimenti e del Farmaco, Università di Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy;
| | - Silvia Bellini
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| | - Paolo Pasquali
- Dipartimento di Sicurezza Alimentare, Nutrizione e Sanità Pubblica Veterinaria, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy;
| | - Giovanni Loris Alborali
- Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna “Bruno Ubertini”, Via Bianchi 7/9, 25124 Brescia, Italy; (S.C.); (G.P.); (F.G.); (L.B.); (A.P.); (F.S.); (M.T.); (F.G.); (S.G.); (C.S.); (S.B.); (G.L.A.)
| |
Collapse
|